Sinopharm
1099.HK
#2828
Rank
โ‚น571.98 B
Marketcap
โ‚น183.29
Share price
1.16%
Change (1 day)
-15.02%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: โ‚น236.42 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น82.21 Billion. In 2025 the company made an earning of โ‚น236.42 Billion, an increase over its 2024 earnings that were of โ‚น221.80 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025โ‚น236.42 B6.59%
2024โ‚น221.80 B-27.86%
2023โ‚น307.47 B-0.73%
2022โ‚น309.73 B-1.72%
2021โ‚น315.14 B11.7%
2020โ‚น282.12 B18.44%
2019โ‚น238.19 B10.85%
2018โ‚น214.88 B3.05%
2017โ‚น208.53 B36.48%
2016โ‚น152.79 B7.11%
2015โ‚น142.65 B12.38%
2014โ‚น126.93 B25.05%
2013โ‚น101.51 B22.54%
2012โ‚น82.84 B35.43%
2011โ‚น61.16 B52.24%
2010โ‚น40.17 B30.99%
2009โ‚น30.67 B60.59%
2008โ‚น19.09 B48.29%
2007โ‚น12.88 B123.29%
2006โ‚น5.76 B